Skip to main content
OpenTrials

Clinical trial condition

Bone Marrow Diseases

Explore clinical trials studying Bone Marrow Diseases. Study availability and eligibility vary by location and protocol.

3,005 public trials 528 recruiting studies
Refine in advanced search Browse all conditions

Bone Marrow Diseases trial results

Completed

ALXN1210 Versus Eculizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Eculizumab

NCT03056040

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Baltimore, Maryland, United States
  • Research Site Detroit, Michigan, United States
View all 51 locations
View Trial Details
Completed

A Non-interventional Study of REVLIMID® (Lenalidomide) Treatment of IPSS Low- or Intermediate-1-risk Myelodysplastic Syndromes Associated With a Deletion 5q or Refractory/Relapsed Mantle Cell Lymphoma in Korea

NCT04036448

Conditions
Bone Marrow Diseases, Disease Attributes, Hematologic Diseases, +15 more
Locations
  • Local Institution - S02 Seoul, Seoul Teugbyeolsi, South Korea
  • Hallym University Medical Center Anyang, South Korea
  • Keimyung University Dongsan Hospital Daegu, South Korea
  • Kyungpook National University Hospital Daegu, South Korea
View all 26 locations
View Trial Details
Completed

Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease

NCT00719888

Conditions
Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +65 more
Locations
  • University of Colorado Hospital Aurora, Colorado, United States
  • VA Puget Sound Health Care System Seattle, Washington, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

A Long-Term Study of the Effects of Orally Administered SAR302503 in Patients With Myelofibrosis

NCT00724334

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Investigational Site Number 840103 La Jolla, California, United States
  • Investigational Site Number 840102 Stanford, California, United States
  • Investigational Site Number 840105 Boston, Massachusetts, United States
  • Investigational Site Number 840106 Ann Arbor, Michigan, United States
View Trial Details
Completed

Phase 2 Study in Japanese Patients With Intermediate-2 or High Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis With Splenomegaly

NCT01692366

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Investigational Site Number 392010 Akita, Japan
  • Investigational Site Number 392002 Bunkyō City, Japan
  • Investigational Site Number 392006 Bunkyō City, Japan
  • Investigational Site Number 392004 Sendai, Japan
View Trial Details
Completed

Study to Separately Evaluate the Activity of Talacotuzumab (JNJ-56022473) or Daratumumab in Transfusion-Dependent Participants With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) Who Are Relapsed or Refractory to Erythropoiesis-Stimulating Agent (ESA) Treatment

NCT03011034

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations
  • Washington University School Of Medicine St Louis, Missouri, United States
  • University of Pennsylvania Abramson Cancer Center Philadelphia, Pennsylvania, United States
  • University of Texas, MD Anderson Cancer Center Houston, Texas, United States
  • ZNA Stuivenberg Antwerp, Belgium
View all 21 locations
View Trial Details

Related conditions